Atika Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Atika Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-75,000	Closed	-$4.66M	–	75
2018 Q3	$4.66M	Hold	75,000	–	–	0.84%	48
2018 Q2	$4.15M	Sell	75,000 -75,000	-50%	-$4.05M	0.8%	47
2018 Q1	$9.49M	Buy	150,000 +86,300	+135%	+$5.55M	3.25%	5
2017 Q4	$3.9M	Buy	63,700 +13,700	+27%	+$857K	1.51%	31
2017 Q3	$3.19M	Buy	+50,000	New	+$2.92M	0.92%	40
2015 Q1	–	Sell	-20,000	Closed	-$1.18M	–	66
2014 Q4	$1.18M	Hold	20,000	–	–	0.86%	45
2014 Q3	$1.02M	Hold	20,000	–	–	0.79%	50
2014 Q2	$970K	Hold	20,000	–	–	0.79%	46
2014 Q1	$1.04M	Buy	+20,000	New	+$1.06M	0.88%	44

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Atika Capital Management's BMY Position: Q1 2016 in Review

Atika Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2016, closing a stake of 62,500 shares — an estimated $4.3M sold.

Atika Capital Management first reported a position in BMY in Q3 2015 and held it in 2 quarters. The position peaked at $4.3M in Q4 2015. 1,524 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

Atika Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2016 after selling out during the quarter.
Atika Capital Management sold 62,500 Bristol-Myers Squibb shares in Q1 2016, an estimated $4.3M.
Atika Capital Management first reported a position in Bristol-Myers Squibb in Q3 2015 and held it in 2 quarters.
Atika Capital Management's Bristol-Myers Squibb position peaked at $4.3M in Q4 2015.
1,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on Atika Capital Management's 13F filing for Q1 2016, filed 16 May 2016.